نتایج جستجو برای: mtb32c

تعداد نتایج: 14  

Aida Gholoobi, Mahboubeh Naderinasab, Maryam Sadat Nabavinia, Mohammad Ramezani, Zahra Meshkat,

Background:  With one-third of the world’s population infected, tuberculosis (TB) is one of the most common infectious diseases and a major public health problem, especially in developing countries. The efficacy of the BCG vaccine for controlling the disease in adults is poor. The development of an effective TB vaccine is a global objective. An effective tuberculosis vaccine should s...

2012
Maryam Sadat Nabavinia Mahboobeh Naderi Nasab Zahra Meshkat Mohammad Derakhshan Mehrangiz Khaje-Karamadini

OBJECTIVE Despite using the Bacille Calmette Guerin (BCG) vaccine, tuberculosis (TB) is still a worldwide disease that kills 2-3 million people each year. Developing a new and more effective vaccine is one way to possibly reduce the morbidity and mortality of TB. The Mtb72F vaccine is one of the important subunit vaccines applied in human clinical trials. In this study, we have constructed an e...

Journal: :Journal of immunology 2004
Yasir A W Skeiky Mark R Alderson Pamela J Ovendale Jeffrey A Guderian Lise Brandt Davin C Dillon Antonio Campos-Neto Yves Lobet Wilfried Dalemans Ian M Orme Steven G Reed

Key Ags of Mycobacterium tuberculosis initially identified in the context of host responses in healthy purified protein derivative-positive donors and infected C57BL/6 mice were prioritized for the development of a subunit vaccine against tuberculosis. Our lead construct, Mtb72F, codes for a 72-kDa polyprotein genetically linked in tandem in the linear order Mtb32(C)-Mtb39-Mtb32(N). Immunizatio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید